Bank of America Securities analyst Joanna Gajuk reiterated a Buy rating on Option Care Health (OPCH – Research Report) today and set a price target of $43.00.
Joanna Gajuk has given her Buy rating due to a combination of factors related to Option Care Health’s recent financial performance and future outlook. The company surpassed expectations by not only beating revenue and Adjusted EBITDA consensus estimates but also raising its full-year guidance, despite concerns over disruptions from the Change system outage. This indicates that the company has robust business fundamentals and potentially increased its market share, signaling a strong competitive position. Additionally, while the system outage temporarily affected operating cash flow, the company’s reaffirmation of its full-year cash flow guidance showcases management’s confidence in their ability to mitigate this setback and maintain financial health.
Further bolstering the Buy rating, Option Care Health demonstrated an ability to effectively manage costs, and its revenue guide increase suggests healthy year-over-year growth. Moreover, the company’s proactive measures, such as stock repurchases, reflect a strategic commitment to shareholder value and a strong belief in the company’s cash flow projections. Given these positives, along with the company’s unchanged margin outlook and potential EBITDA growth from strategic deals not included in the guidance, Gajuk has set a price objective that represents a significant upside from the current trading price, reinforcing the Buy recommendation.
Based on the recent corporate insider activity of 40 insiders, corporate insider sentiment is neutral on the stock.
TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.
Option Care Health (OPCH) Company Description:
Option Care Health, Inc. provides home and alternate site infusion services. The company was founded in 1996 and is headquartered in Bannockburn, IL.
